Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. operates as a subsidiary of Stevanato Holding S.R.L.
Revenue of Stevanato Group S.p.A. (STVN)
Revenue in 2023 (TTM): $1.09 B
According to Stevanato Group S.p.A.'s latest financial reports the company's current revenue (TTM) is $1.09 B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of Stevanato Group S.p.A.
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $1.09 B | $341.68 M | $272.35 M | $189.55 M | $145.63 M |
| 2022 | $983.7 M | $319.8 M | $256.4 M | $187.6 M | $142.85 M |
| 2021 | $843.9 M | $265.4 M | $226.93 M | $165.7 M | $134.32 M |
| 2020 | $662.04 M | $194.18 M | $156.38 M | $96.28 M | $78.51 M |
| 2019 | $536.54 M | $138.02 M | $106.54 M | $54.71 M | $39.2 M |